2nd Quarter - Report

MEDCO HEALTH SOLUTIONS, INC for MEDCO HEALTH SOLUTIONS INC

Period 2nd Quarter 2008 Filed Jul 18, 2008 Signed by Peter Begans, Vice President, Federal Government Affairs

Official filing
Firm
MEDCO HEALTH SOLUTIONS, INC
Client
MEDCO HEALTH SOLUTIONS INC
Income
—
Expenses
$508,492
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Medicare Part D Contract Disclsoure Requirements, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs, Over-the-Counter Drug Dispersement, Carve-out of Generic Drugs from State Medicaid Generic Substitution Laws HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2008; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

LobbyistCovered position, as disclosed
PETER BEGANS —
ALLYSON BLANDFORD New Professional Staff Member (2002-2007)
BILL HEAD —
KIMBERLY LINTHICUM New LC, LA, LD (1995-2000)
HEATHER STEWART —

Contacted: Federal Trade Commission (FTC); Food & Drug Administration (FDA); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Drug Enforcement Administration (DEA); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; SENATE; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Justice, Dept of (DOJ); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS)

Bills named: H.R. 5683 (110th), H.R. 3140 (110th), S. 316 (110th), H.R. 3193 (110th), H.R. 4296 (110th), H.R. 5629 (110th), S. 1814 (110th), H.R. 6357 (110th), H.R. 1956 (110th), H.R. 971 (110th), H.R. 1474 (110th), H.R. 2606 (110th), H.R. 493 (110th), H.R. 2567 (110th), H.R. 3800 (110th), H.R. 3932 (110th), H.R. 1432 (110th), H.R. 3090 (110th), H.R. 2914 (110th), H.R. 2970 (110th)

Medicare/Medicaid MMM

Medicare Part D, Prompt Payment of Pharmacy Claims, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Tracking the Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

LobbyistCovered position, as disclosed
PETER BEGANS —
ALLYSON BLANDFORD New Professional Staff Member (2002-2007)
BILL HEAD —
KIMBERLY LINTHICUM New LC, LA, LD (1995-2000)
HEATHER STEWART —

Contacted: Drug Enforcement Administration (DEA); Agency for Healthcare Research & Quality (AHRQ); Justice, Dept of (DOJ); SENATE; Labor, Dept of (DOL); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Congressional Budget Office (CBO)

Bills named: H.R. 2606 (110th), H.R. 6331 (110th), H.R. 2567 (110th), H.R. 4296 (110th), H.R. 3700 (110th), H.R. 2914 (110th), H.R. 6252 (110th)

Pharmacy PHA

Electronic Prescribing, Rule for Calculating Average Manufacturing Price for Prescription Drugs, Pharmacy Payments, Antitrust Exemption for Independent Pharmacies, Internet Pharmacies, Electronic Prescribing of Controlled Substances HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

LobbyistCovered position, as disclosed
PETER BEGANS —
ALLYSON BLANDFORD New Professional Staff Member
BILL HEAD —
KIMBERLY LINTHICUM New LC, LA, LD (1995-2000)
HEATHER STEWART —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); Justice, Dept of (DOJ); Agency for Healthcare Research & Quality (AHRQ); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Congressional Budget Office (CBO); Food & Drug Administration (FDA)

Bills named: H.R. 3090 (110th), H.R. 1474 (110th), H.R. 2970 (110th), H.R. 3140 (110th), H.R. 971 (110th), H.R. 3193 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.